dbId
9674412
displayName
Sorafenib has broader effectiveness against many imatinib-re...
schemaClass
Summation
text
Sorafenib has broader effectiveness against many imatinib-resistant PDGFR mutations that sunitinib, however both D842V and S601P show resistance to inhibition by sorafenib as well (Heinrich et al, 2012; Salemi et al, 2009; reviewed in Corless et al, 2011).